• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients.肿瘤微环境中的驻留记忆 CD8+T 细胞介导乳腺癌患者的生存。
JCI Insight. 2019 Oct 3;4(19):130000. doi: 10.1172/jci.insight.130000.
2
Functional Heterogeneity of CD4 Tumor-Infiltrating Lymphocytes With a Resident Memory Phenotype in NSCLC.非小细胞肺癌中具有驻留记忆表型的 CD4 肿瘤浸润淋巴细胞的功能异质性。
Front Immunol. 2018 Nov 16;9:2654. doi: 10.3389/fimmu.2018.02654. eCollection 2018.
3
Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.表达组织驻留记忆标志物 CD103 的肿瘤浸润淋巴细胞与高级别浆液性卵巢癌患者生存率的提高相关。
Clin Cancer Res. 2014 Jan 15;20(2):434-44. doi: 10.1158/1078-0432.CCR-13-1877. Epub 2013 Nov 4.
4
CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma.CD8+CD103+组织驻留记忆 T 细胞在皮肤鳞状细胞癌中传递降低的保护性免疫。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001807.
5
The Emerging Role of CD8 Tissue Resident Memory T (T) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin.CD8 组织驻留记忆 T(T)细胞在抗肿瘤免疫中的新兴作用:CD103 整合素的独特功能贡献。
Front Immunol. 2018 Aug 15;9:1904. doi: 10.3389/fimmu.2018.01904. eCollection 2018.
6
Concomitant Expression of CD39, CD69, and CD103 Identifies Antitumor CD8 T Cells in Breast Cancer Implications for Adoptive Cell Therapy.CD39、CD69 和 CD103 的共表达鉴定了乳腺癌中的抗肿瘤 CD8 T 细胞,这对过继细胞治疗有影响。
Curr Pharm Biotechnol. 2024;25(13):1747-1757. doi: 10.2174/1389201025666230901094219.
7
Tissue-resident memory CD103+CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker.结直肠癌组织驻留记忆 CD103+CD8+T 细胞:作为预后和预测肝转移生物标志物的意义。
Cancer Immunol Immunother. 2024 Jul 2;73(9):176. doi: 10.1007/s00262-024-03709-2.
8
CD103 and Intratumoral Immune Response in Breast Cancer.CD103 与乳腺癌的肿瘤内免疫反应
Clin Cancer Res. 2016 Dec 15;22(24):6290-6297. doi: 10.1158/1078-0432.CCR-16-0732. Epub 2016 Jun 7.
9
Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.分析复发性喉鳞状细胞癌中浸润的 CD103 驻留记忆 T 细胞含量。
Cancer Immunol Immunother. 2019 Feb;68(2):213-220. doi: 10.1007/s00262-018-2256-3. Epub 2018 Oct 25.
10
Characterization of CD103 CD8 tissue-resident T cells in esophageal squamous cell carcinoma: may be tumor reactive and resurrected by anti-PD-1 blockade.CD103+CD8+ 食管鳞状细胞癌组织驻留 T 细胞的特征:可能是肿瘤反应性的,并可被抗 PD-1 阻断剂复活。
Cancer Immunol Immunother. 2020 Aug;69(8):1493-1504. doi: 10.1007/s00262-020-02562-3. Epub 2020 Apr 13.

引用本文的文献

1
IL-6R blockade combined with immunosuppressants alleviates adult-onset Still's disease through immune remodeling: a mass cytometry study.白细胞介素-6受体阻断联合免疫抑制剂通过免疫重塑缓解成人斯蒂尔病:一项质谱流式细胞术研究
J Transl Med. 2025 Jun 2;23(1):610. doi: 10.1186/s12967-025-06597-x.
2
CD8 T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance.乳腺癌肿瘤及引流淋巴结中的CD8 T细胞:PD-1水平、效应功能及预后相关性
Oncoimmunology. 2025 Dec;14(1):2502354. doi: 10.1080/2162402X.2025.2502354. Epub 2025 May 12.
3
A potential therapeutic molecule target: lncRNA AK023507 inhibits the metastasis of breast cancer by regulating the WNT/DOCK4/β-catenin axis.一种潜在的治疗性分子靶点:长链非编码RNA AK023507通过调控WNT/DOCK4/β-连环蛋白轴抑制乳腺癌转移。
Breast Cancer Res Treat. 2025 Jun;211(3):727-741. doi: 10.1007/s10549-025-07695-6. Epub 2025 Apr 9.
4
Spatial proximity of CD8 T cells to tumor cells predicts neoadjuvant therapy efficacy in breast cancer.CD8 T细胞与肿瘤细胞的空间接近程度可预测乳腺癌新辅助治疗的疗效。
NPJ Breast Cancer. 2025 Feb 10;11(1):13. doi: 10.1038/s41523-025-00728-9.
5
Immunoscore CD3/CD8 and FOXP3 Expression Correlate to Neoadjuvant Chemotherapy Response in Triple Negative Breast Cancer: A Case-Control Study.免疫评分CD3/CD8和FOXP3表达与三阴性乳腺癌新辅助化疗反应相关:一项病例对照研究
Asian Pac J Cancer Prev. 2025 Jan 1;26(1):117-126. doi: 10.31557/APJCP.2025.26.1.117.
6
Integrating immunotherapy with conventional treatment regime for breast cancer patients- an amalgamation of armamentarium.将免疫疗法与乳腺癌患者的常规治疗方案相结合——一种武器的融合。
Front Immunol. 2024 Nov 1;15:1477980. doi: 10.3389/fimmu.2024.1477980. eCollection 2024.
7
Tissue-Resident T Cells in Clinical Response and Immune-Related Adverse Events of Immune Checkpoint Blockade.组织驻留T细胞在免疫检查点阻断的临床反应和免疫相关不良事件中的作用
Clin Cancer Res. 2024 Dec 16;30(24):5527-5534. doi: 10.1158/1078-0432.CCR-23-3296.
8
Computational methods and biomarker discovery strategies for spatial proteomics: a review in immuno-oncology.计算方法和生物标志物发现策略在空间蛋白质组学中的应用:免疫肿瘤学综述。
Brief Bioinform. 2024 Jul 25;25(5). doi: 10.1093/bib/bbae421.
9
Immunologic Mechanisms of BCc1 Nanomedicine Synthesized by Nanochelating Technology in Breast Tumor-bearing Mice: Immunomodulation and Tumor Suppression.纳米螯合技术合成的 BCc1 纳米药物在荷乳腺癌小鼠中的免疫机制:免疫调节与肿瘤抑制。
Anticancer Agents Med Chem. 2024;24(19):1442-1456. doi: 10.2174/0118715206302153240723053521.
10
The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy.乳腺癌肿瘤微环境与精准医学:免疫原性及有利于免疫治疗反应的条件。
J Natl Cancer Cent. 2024 Jan 26;4(1):14-24. doi: 10.1016/j.jncc.2024.01.004. eCollection 2024 Mar.

本文引用的文献

1
Tumor Resident Memory T Cells: New Players in Immune Surveillance and Therapy.肿瘤驻留记忆 T 细胞:免疫监视和治疗的新角色。
Front Immunol. 2018 Sep 11;9:2076. doi: 10.3389/fimmu.2018.02076. eCollection 2018.
2
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.乳腺肿瘤微环境中多样化免疫表型的单细胞图谱
Cell. 2018 Aug 23;174(5):1293-1308.e36. doi: 10.1016/j.cell.2018.05.060. Epub 2018 Jun 28.
3
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis.单细胞分析乳腺癌 T 细胞揭示了与改善预后相关的组织驻留记忆亚群。
Nat Med. 2018 Jul;24(7):986-993. doi: 10.1038/s41591-018-0078-7. Epub 2018 Jun 25.
4
Bystander CD8 T cells are abundant and phenotypically distinct in human tumour infiltrates.在人类肿瘤浸润物中,旁观者 CD8 T 细胞丰富且表型独特。
Nature. 2018 May;557(7706):575-579. doi: 10.1038/s41586-018-0130-2. Epub 2018 May 16.
5
CD103CD8 T lymphocytes in non-small cell lung cancer are phenotypically and functionally primed to respond to PD-1 blockade.CD103CD8 T 淋巴细胞在非小细胞肺癌中表现出对 PD-1 阻断的应答的表型和功能的预先致敏。
Cell Immunol. 2018 Mar;325:48-55. doi: 10.1016/j.cellimm.2018.02.002. Epub 2018 Feb 7.
6
QuPath: Open source software for digital pathology image analysis.QuPath:用于数字病理学图像分析的开源软件。
Sci Rep. 2017 Dec 4;7(1):16878. doi: 10.1038/s41598-017-17204-5.
7
T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire.早期乳腺癌肿瘤的 T 细胞受体测序鉴定出 T 细胞库的克隆结构发生改变。
Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):E10409-E10417. doi: 10.1073/pnas.1713863114. Epub 2017 Nov 14.
8
Resident memory T cells in the skin mediate durable immunity to melanoma.皮肤中的驻留记忆T细胞介导对黑色素瘤的持久免疫。
Sci Immunol. 2017 Apr 14;2(10). doi: 10.1126/sciimmunol.aam6346.
9
Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8 T cells.增强抗肿瘤免疫需要驻留和循环记忆 CD8 T 细胞之间的相互作用。
Nat Commun. 2017 Jul 17;8:16073. doi: 10.1038/ncomms16073.
10
Induction of resident memory T cells enhances the efficacy of cancer vaccine.诱导驻留记忆 T 细胞增强癌症疫苗的疗效。
Nat Commun. 2017 May 24;8:15221. doi: 10.1038/ncomms15221.

肿瘤微环境中的驻留记忆 CD8+T 细胞介导乳腺癌患者的生存。

Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients.

机构信息

Department of Immuno-Oncology.

Light Microscopy and Digital Imaging Core.

出版信息

JCI Insight. 2019 Oct 3;4(19):130000. doi: 10.1172/jci.insight.130000.

DOI:10.1172/jci.insight.130000
PMID:31465302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6795408/
Abstract

CD8+ tumor-infiltrating lymphocytes (TILs) correlate with relapse-free survival (RFS) in most cancer types, including breast cancer. However, subset composition, functional status, and spatial location of CD8+ TILs in relation to RFS in human breast tumors remain unclear. Spatial tissue analysis via quantitative immunofluorescence showed that infiltration of CD8+ T cells into cancer islands was more significantly associated with RFS than CD8+ T cell infiltration into either tumor stroma or total tumor. Localization into cancer islands within tumors is mediated by expression of the integrin CD103, which is a marker for tissue-resident memory T cells (TRMs). Analysis of fresh tumor samples revealed that CD8+ TRMs are functionally similar to other CD8+ TILs, suggesting that the basis of their protective effect is their spatial distribution rather than functional differences. Indeed, CD103+ TRMs, as compared with CD103-CD8+ TILs, are enriched within cancer islands, and CD8+ TRM proximity to cancer cells drives the association of CD8+ TIL densities with RFS. Together, these findings reveal the importance of cancer island-localized CD8+ TRMs in surveillance of the breast tumor microenvironment and as a critical determinant of RFS in patients with breast cancer.

摘要

CD8+ 肿瘤浸润淋巴细胞 (TILs) 与大多数癌症类型(包括乳腺癌)的无复发生存期 (RFS) 相关。然而,人类乳腺癌中与 RFS 相关的 CD8+TIL 的亚群组成、功能状态和空间位置仍不清楚。通过定量免疫荧光的空间组织分析显示,CD8+T 细胞浸润到癌巢中与 RFS 的相关性比 CD8+T 细胞浸润到肿瘤基质或总肿瘤中更为显著。肿瘤内癌症巢中的定位是由整合素 CD103 的表达介导的,CD103 是组织驻留记忆 T 细胞 (TRM) 的标志物。对新鲜肿瘤样本的分析表明,CD8+TRM 与其他 CD8+TIL 具有相似的功能,这表明其保护作用的基础是其空间分布而不是功能差异。事实上,与 CD103-CD8+TIL 相比,CD103+TRM 更富集于癌巢内,而 CD8+TRM 与癌细胞的接近程度则驱动了 CD8+TIL 密度与 RFS 的相关性。总之,这些发现揭示了癌巢定位的 CD8+TRM 在监测乳腺癌微环境中的重要性,以及其作为乳腺癌患者 RFS 的关键决定因素。